Back
Avalo Therapeutics Stock Price Chart

Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
7
AVTX
Avalo Therapeutics
Last Price:
$4.75
Seasonality Move:
-5.51%
7 Day Trial
ALL ACCESS PASS
$
7

Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVTX is experiencing slight selling pressure.
Avalo Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.71 | Sell |
20-day SMA: | 7.08 | Sell |
50-day SMA: | 7.37 | Sell |
200-day SMA: | 9.51 | Sell |
8-day EMA: | 5.69 | Sell |
20-day EMA: | 6.57 | Sell |
50-day EMA: | 7.28 | Sell |
200-day EMA: | 21.14 | Sell |
Avalo Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.68 | Sell |
Relative Strength Index (14 RSI): | 29.33 | Sell |
Chaikin Money Flow: | -8266 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.03 - 8.35) | Sell |
Bollinger Bands (100): | (6.6 - 9.76) | Sell |
Avalo Therapeutics Technical Analysis
Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Avalo Therapeutics Stock
Is Avalo Therapeutics Stock a Buy?
-
Avalo Therapeutics share price is 4.90 while AVTX 8-day simple moving average is 5.71, which is a Sell signal.
-
The stock price of AVTX is 4.90 while Avalo Therapeutics 20-day SMA is 7.08, which makes it a Sell.
-
Avalo Therapeutics 50-day simple moving average is 7.37 while AVTX share price is 4.90, making it a Sell technically.
-
AVTX stock price is 4.90 and Avalo Therapeutics 200-day simple moving average is 9.51, creating a Sell signal.
AVTX Technical Analysis vs Fundamental Analysis
Sell
7
Avalo Therapeutics (AVTX)
is a Sell
Is Avalo Therapeutics a Buy or a Sell?
-
Avalo Therapeutics stock is rated a SellThe current Avalo Therapeutics [AVTX] share price is $4.90. The Score for AVTX is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
Avalo Therapeutics Stock Info
Market Cap:
52.3M
Price in USD:
4.90
Share Volume:
33.4K
Avalo Therapeutics 52-Week Range
52-Week High:
18.79
52-Week Low:
4.44
Sell
7
Avalo Therapeutics (AVTX)
is a Sell
Avalo Therapeutics Share Price Forecast
-
What is the Avalo Therapeutics stock price today?The Avalo Therapeutics stock price is 4.90 USD today.
-
Will AVTX stock go up or go down?Avalo Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Avalo Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Avalo Therapeutics is overvalued.
Is Avalo Therapeutics Stock a Buy?
-
Avalo Therapeutics share price is 4.90 while AVTX 8-day exponential moving average is 5.69, which is a Sell signal.
-
The stock price of AVTX is 4.90 while Avalo Therapeutics 20-day EMA is 6.57, which makes it a Sell.
-
Avalo Therapeutics 50-day exponential moving average is 7.28 while AVTX share price is 4.90, making it a Sell technically.
-
AVTX stock price is 4.90 and Avalo Therapeutics 200-day simple moving average is 21.14, creating a Sell signal.
Fundamental Analysis of Avalo Therapeutics
Is Avalo Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $3.33 per share, a decrease next quarter of $0.46 per share, a decrease this year of $18.12 per share, and an increase next year of $1.00 per share.
Technical Analysis of Avalo Therapeutics
Should I short Avalo Therapeutics stock?
-
AVTX Moving Average Covergence Divergence (MACD) indicator is -0.68, suggesting Avalo Therapeutics is a Sell
-
Avalo Therapeutics Relative Strength Index (RSI) is 29.33, which suggest Avalo Therapeutics is oversold
-
The Bollinger Bands (25) for Avalo Therapeutics is (6.03 - 8.35), which suggest Avalo Therapeutics is a Sell
-
The Bollinger Bands (100) for Avalo Therapeutics is (6.6 - 9.76), which suggest Avalo Therapeutics is a Sell
* Avalo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.